DexCom (DXCM) said late Tuesday that it appointed Jon Coleman as chief commercial officer, who has more than 30 years of experience across multiple healthcare segments and channels.
Coleman served as an executive officer of Masimo (MASI), where he held roles of increasing responsibility across his 15-year tenure. He also held roles at Pfizer's (PFE) consumer healthcare business, DexCom said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.